How can I prevent side effects
Petrelintide, a nascent form of treatment known as an amylin analog, adds to Roche's existing GLP-1 offering including CT-388 and once-daily oral candidate CT-996, which were both acquired as part of Roche's first foray into the obesity market with the purchase in late 2023 of U.S
Assuming a 4-week renewal cycle, this suggests a current count of fully committed patients of about 8 million Americans
The pill form is only approved for use in adults at this time, although studies in children are ongoing
It is where Semaglutide steps in, gracefully turning the process into a long-term weight management program
These research-stage amylin-based candidates differ in receptor focus, molecular design, clinical evidence, side-effect profile, and development strategy